Lupin Ltd launches U.S. generic raltegravir 600 mg tablets after FDA approval; it is the exclusive first-to-file applicant
- Bioequivalent to Isentress HD; indicated for certain adult and pediatric patients with HIV-1, in combination with other antiretroviral agents.
- Eligible for 180-day generic drug exclusivity.
- U.S. annual sales were estimated at US$26 million for the 12 months ended September 2026, per IQVIA.